{"id":"8b7b3432-73a4-4220-9227-d1fbe2df9ef4","arxiv_id":"2508.15163","paper_version":1,"verdict":"UNVERDICTED","confidence":"LOW","novelty_score":5.0,"correctness_risk":"unknown","formal_verification":"none","parameter_count":4,"one_line_summary":"A computational model estimates pancreatic duct pressure non-invasively from MRCP geometry, with reported agreement against ERCP pressure measurements.","lead":"This medical-physics preprint proposes estimating pancreatic duct pressure from MRCP images and flow simulation, claiming strong correlation with invasive measurements. If validated, it could let doctors assess pancreatic duct hypertension without an invasive procedure.","discovery_kind":"new_application","skeptic_critique":{"model":"deepseek-v4-flash","headline":"Abstract-level evidence cannot establish non-invasive PDP estimation: flow-parameter provenance and calibration vs. ERCP validation are unspecified, and the provided full text is a different manuscript.","rationale":"The reader correctly identified the weakest assumption as the sufficiency of MRCP geometry plus assumed flow parameters and the validity of ERCP as ground truth. My concern deepens this: the abstract gives no indication of how the flow parameters were set, and the provided full-text mismatch means those details are unavailable. If the parameters were fitted to the ERCP pressures, the correlation is circular. This is the single most load-bearing issue because it affects both the CFD validation and the derived quasi-1D model, and it would determine whether the method generalizes beyond the training cohort. The reader's verdict is UNVERDICTED due to insufficient materials; my analysis does not change that verdict, so I recommend UNCHANGED. I agree with the reader's weakest_assumption, and my concrete test directly targets the circularity risk.","tokens_in":16423,"tokens_out":2710,"duration_ms":34478,"concrete_test":"Obtain the actual full text of arXiv:2508.15163 and inspect the Methods section. Specifically: (1) List all flow parameters and their sources; (2) determine whether any parameter was calibrated against ERCP pressure measurements. If calibration occurred, perform a leave-one-patient-out cross-validation with parameters re-estimated only on training patients and evaluate the correlation with ERCP pressures on held-out patients. If the correlation degrades substantially, the non-invasive predictive claim fails. If parameters were fixed independently and the held-out correlation remains strong, the concern is resolved. Also check whether ERCP catheterization itself alters duct pressure (e.g., sedation, fluid infusion), which would invalidate the ground truth.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The central claim—that MRCP-derived geometry plus flow parameters yield accurate PDP—rests on two unverified links. First, the abstract never states whether pancreatic juice flow rate, viscosity, and duct wall compliance are measured, taken from literature, or fitted to the ERCP pressure outcomes. If these parameters were calibrated against the same pressures used for validation, the reported 'strong correlation' is partly circular and will not generalize to new patients. Second, the full text supplied for review (arXiv:2508.15169) is a computer-vision paper on city scene generation, not the pancreatic duct hypertension study, so the governing equations, boundary conditions, and compliance model cannot be inspected. This is a mechanical material mismatch, not an accusation. The load-bearing insecurity is therefore the identifiability of the physiological parameters: unless they are fixed a priori or independently measurable, the method cannot be considered a non-invasive diagnostic tool. The abstract's secondary claim—that the quasi-1D model agrees with CFD—only transfers trust from CFD to the reduced model; it does not validate the underlying physiology.","agreement_with_reader":"agree"},"referee_report":{"model":"deepseek-v4-flash","summary":"The submission under review consists of an abstract for a physics/med-ph paper proposing non-invasive pancreatic duct pressure (PDP) estimation from MRCP-derived duct geometry combined with computational fluid dynamics (CFD), plus a quasi-one-dimensional (Q1D) analytical model. The abstract claims strong correlation between simulated pressure gradients and in-vivo ERCP measurements, as well as with clinical outcomes such as pain relief after ductal decompression, and strong concordance between the Q1D model and CFD. However, the supplied full text is arXiv:2508.15169, an unrelated computer-vision paper on city mesh-guided outdoor scene generation (MeSS). No methods, equations, boundary conditions, patient data, statistical analyses, or validation details for the described pancreatic study are present in the submission. Consequently, the central claims cannot be inspected or verified from the submitted manuscript.","tokens_in":16667,"tokens_out":2273,"duration_ms":27141,"significance":"If the claims were substantiated, the proposed MRCP-based PDP estimation could address a real clinical need by replacing invasive ERCP pressure measurements in chronic pancreatitis. The potential significance is therefore genuine. However, the current submission provides only an abstract-level assertion; no quantitative correlations, sample sizes, parameter sets, or governing equations are available. The claimed Q1D-vs-CFD concordance, even if established, would only demonstrate that the reduced model reproduces the CFD physics; it would not independently validate the physiological assumptions embedded in the CFD model. As submitted, the manuscript does not provide enough evidence to assess feasibility, accuracy, or generalizability of the method.","major_comments":[{"comment":"The full text supplied with the submission is arXiv:2508.15169, a computer-vision paper titled 'MeSS: City Mesh-Guided Outdoor Scene Generation,' which is unrelated to the pancreatic duct hypertension study described in the abstract. None of the methods, governing equations, boundary conditions, mesh generation, CFD solver, or Q1D model derivations are available. This is a load-bearing integrity issue: the manuscript cannot be scientifically reviewed in this state.","section":"Full text"},{"comment":"The abstract states that simulated pressure gradients showed 'strong correlation' with ERCP measurements and 'strong concordance' with CFD results, but reports no correlation coefficients, R² values, limits of agreement, sample sizes, patient demographics, or statistical significance. Without these, the strength of the claimed associations cannot be evaluated. The clinical outcome 'pain relief following ductal decompression' is also undefined in terms of measurement instrument and follow-up interval.","section":"Abstract"},{"comment":"The method depends on unstated physiological parameters: pancreatic juice flow rate, fluid viscosity, and duct wall compliance. The abstract does not indicate whether these are measured, taken from literature, or fitted to the ERCP pressure outcomes. If any of these parameters were calibrated against the same pressure values used for validation, the reported correlation would be partly circular. A clear calibration/validation split with pre-specified parameters or independent measurement is required.","section":"Abstract, parameter provenance"},{"comment":"The abstract's supporting claim that the quasi-one-dimensional model shows 'strong concordance' with CFD tests only validates the reduced-order approximation against the same computational framework; it does not validate the underlying physiological model against ground-truth pressures. Independent validation of the Q1D model against ERCP measurements is needed, along with uncertainty quantification that propagates geometric segmentation error and parameter uncertainty into PDP estimates.","section":"Q1D model validation"}],"minor_comments":[{"comment":"The abstract does not state the number of patients or ducts analyzed, the range of pancreatic duct pressures encountered, or the criteria for selecting subjects. Reporting these would greatly improve interpretability.","section":"Abstract"},{"comment":"The title, abstract, and full text belong to different papers. If an administrative error occurred in assembling the submission, a corrected version with the actual methods and results must be provided.","section":"General"}],"recommendation":"reject","confidential_remarks":"This appears to be a submission where the abstract and full text are from entirely different manuscripts. The abstract describes a plausible and clinically interesting study, but the absence of any corresponding methods/results prevents even a preliminary scientific assessment. If this is a metadata or packaging error, the authors should resubmit the correct full text; the current version cannot be reviewed as a medical-physics manuscript."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"Quick take before the details: I only had the abstract to judge. The full text attached to this manuscript is a city-scene-generation paper (MeSS), not the pancreatic duct pressure study—a materials mix-up, not a flaw in the work. On the abstract alone, the core idea is genuinely interesting: use patient-specific MRCP geometry with CFD to estimate pancreatic duct pressure, then distill it into a quasi-1D model that could be practical clinically. That's a sensible progression, and the clinical motivation—non-invasive diagnosis of duct hypertension in chronic pancreatitis—is real.\n\nWhat the abstract does well: it states a clear hypothesis, a plausible pipeline, and a dual validation story (against ERCP pressures and against clinical outcomes like pain relief after decompression). The Q1D model's concordance with CFD is a reasonable internal consistency check, though it only transfers trust from the full simulation to the reduced model; it doesn't independently validate the underlying physiology.\n\nThe soft spots are the usual ones for this kind of work, and they're real. The abstract never reports correlation coefficients, sample sizes, or whether the flow parameters (juice flow rate, viscosity, wall compliance) were measured, taken from literature, or fitted to the ERCP data. If those parameters were calibrated against the same pressures used for validation, the 'strong correlation' is partly circular and won't generalize. The Q1D agreement with CFD says nothing about that. None of this is fatal from the abstract alone—it's the standard question you'd ask of any inverse modeling paper.\n\nWho's this for: a clinical biomechanics audience, pancreatic/GI researchers, and computational physiology folks. If the full paper is as careful as the abstract suggests, it could be a useful contribution. But I can't verify that from here.\n\nRecommendation: this deserves a serious referee. Send it to peer review with a specific request to scrutinize parameter provenance and whether the ERCP data were used in model fitting or kept separate for validation. If that split is clean, the paper has value; if not, the claims need to be scaled back. I'd desk-reject only if the methods section turns out to be as thin as the abstract.","headline":"Abstract-only review: the pancreatic duct pressure idea is promising and plausible, but the attached full text is a different paper and the abstract lacks the quantitative validation details needed to trust the 'strong correlation' claims.","tokens_in":17108,"tokens_out":2287,"would_cite":false,"duration_ms":24832,"reading_group":"maybe","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"The paper claims that pancreatic duct pressure — the quantity thought to drive pain in chronic pancreatitis — can be estimated non-invasively from MRCP imaging and computational flow modeling, replacing invasive ERCP catheter measurements.","keywords":["pancreatic duct hypertension","pancreatic duct pressure","chronic pancreatitis","MRCP","computational fluid dynamics","ERCP","quasi-one-dimensional model","non-invasive diagnosis"],"falsifier":"A prospective cohort where ERCP catheter pressure is measured during the same session as MRCP: if the CFD or quasi-1D-model pressure predictions, generated without knowledge of the catheter readings, fail to reproduce measured pressures to clinical accuracy—or if physiological variations in assumed flow rate and viscosity swing the predicted pressure enough to change treatment decisions—the central claim is falsified.","tokens_in":16332,"feed_emoji":"🩻","tokens_out":4382,"duration_ms":45706,"temperature":0.7,"pith_summary":"The paper claims that pancreatic duct pressure — the quantity thought to drive pain in chronic pancreatitis — can be estimated non-invasively from MRCP imaging and computational flow modeling, replacing invasive ERCP catheter measurements. The authors build patient-specific three-dimensional ductal models from MRCP data and simulate intraductal pressure distributions with computational fluid dynamics. They report that the simulated pressure gradients correlate strongly with in vivo ERCP measurements and with clinical outcomes such as pain relief after ductal decompression. They also present a simplified quasi-one-dimensional analytical model that predicts pressure from ductal geometry and flow parameters, matching the full CFD results. If these claims hold, MRCP-based pressure estimation would become a practical diagnostic tool for detecting pancreatic duct hypertension and guiding treatment decisions in chronic pancreatitis.","feed_headline":"MRI flow model predicts pancreatic duct pressure non-invasively","feed_subtitle":"Simulated pressures match invasive ERCP readings, a path to non-invasive chronic pancreatitis diagnosis.","key_machinery":"The approach rests on two linked components: patient-specific three-dimensional ductal geometry reconstructed from MRCP imaging, which provides anatomical fidelity for the flow simulation, and a computational fluid dynamics model that computes the intraductal pressure distribution. The clinically usable vehicle is the quasi-one-dimensional analytical model, which predicts pancreatic duct pressure directly from ductal geometry and assumed flow parameters; the 3D CFD simulation serves as the accuracy reference against which the reduced model is validated.","core_discovery":"The central claim is that pancreatic ductal hypertension can be diagnosed non-invasively by combining magnetic resonance cholangiopancreatography (MRCP) with computational fluid dynamics (CFD). The authors reconstruct patient-specific three-dimensional ductal geometries from MRCP scans and simulate intraductal pressure distributions, reporting that the computed pressure gradients match invasive ERCP measurements and clinical outcomes. They then reduce the full three-dimensional simulation to a quasi-one-dimensional analytical model that takes ductal geometry and flow parameters as inputs and reproduces the CFD pressure predictions. The paper's stated discovery is the feasibility and clinical","pith_inferences":["The same geometry-plus-flow framework could plausibly extend to other ductal systems where pressure matters, such as the bile duct or salivary ducts, though the paper does not claim this.","To guide therapy, a clinically validated pressure threshold for 'hypertension' would need to be established from larger outcome-linked cohorts; the abstract does not state such a threshold.","The reported correlation between pressure estimates and pain relief after decompression suggests pressure contributes to pain, but whether it is the sole driver remains untested; other ductal or parenchymal factors could be involved.","A natural prospective test is to post MRCP-based predictions before ERCP and compare them with catheter readings, which would show whether the parameter-fitting generalizes beyond the cohort used in this study."],"forward_implications":["Non-invasive pancreatic duct pressure estimation could become a routine part of chronic pancreatitis workup, identifying candidates for ductal decompression without an invasive ERCP.","Repeated MRCP-based pressure estimates could let clinicians track pressure changes over time and after therapy, enabling longitudinal monitoring of disease progression.","The quasi-one-dimensional model could be embedded in radiology software to generate pressure estimates directly from MRCP-derived duct geometry, cutting computational cost enough for clinical use.","If pressures can be estimated reliably, diagnostic ERCPs performed purely to measure pressure could be reserved for interventions, reducing procedural risk for patients."],"supporting_citations":[],"fun_headline_variants":["MRI flow sim gauges pancreatic duct pressure","Noninvasive duct pressure via MRI and flow modeling","CFD on MRCP predicts pancreatic duct hypertension","Flow model from MRI matches invasive ERCP pressure","MRI-based simulation reads pancreas duct pressure"],"cache_read_input_tokens":2688,"weakest_assumption_plain":"The estimate assumes MRCP-derived duct geometry plus assumed flow parameters (pancreatic juice flow rate, viscosity, duct wall compliance) are sufficient to reproduce true intraductal pressures, with ERCP pressure measurement treated as the ground truth.","fun_headline_variants_meta":{"raw":{"variants":["MRI flow sim gauges pancreatic duct pressure","Noninvasive duct pressure via MRI and flow modeling","CFD on MRCP predicts pancreatic duct hypertension","Flow model from MRI matches invasive ERCP pressure","MRI-based simulation reads pancreas duct pressure"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.000258,"raw_usage":{"total_tokens":1408,"prompt_tokens":724,"completion_tokens":684,"prompt_tokens_details":{"cached_tokens":256},"prompt_cache_hit_tokens":256,"prompt_cache_miss_tokens":468,"completion_tokens_details":{"reasoning_tokens":630}},"tokens_in":468,"tokens_out":684,"duration_ms":9623,"temperature":1.0,"reasoning_tokens":630,"cache_read_input_tokens":256,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-05T18:02:39.419490+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"A prospective cohort where ERCP catheter pressure is measured during the same session as MRCP: if the CFD or quasi-1D-model pressure predictions, generated without knowledge of the catheter readings, fail to reproduce measured pressures to clinical accuracy—or if physiological variations in assumed flow rate and viscosity swing the predicted pressure enough to change treatment decisions—the central claim is falsified.","supporting_citations":[],"review_version":1}